Skip to main content Skip to page footer
ÖAW
EULIFE
LIBRA

Funding

Stefan Kubicek

Breakthrough T1D Strategic Research Agreement Single Project
Duration 2022 - 2025

Breakthrough T1D (formerly JDRF)

Stefan Kubicek Group

Targeting mannosylation for regenerating beta cell mass